Reviews: Zotarolimus stent shows efficacy in diabetes patients

04/22/2013 | Healio

Resolute Integrity's zotarolimus-eluting stent helped reduce target vessel failure rate and proved safe and effective in patients with diabetes, an analysis revealed. Another review showed insulin-treated diabetes patients had higher target lesion failure rates than non–insulin-treated diabetes patients. The results appear in JACC: Cardiovascular Interventions.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY